Brahmbhatt Millie, Palla Kavita, Kossifologos Annette, Mitchell Dayna, Lee Todd
Edward Hines, Jr. VA Hospital, Hines, IL, USA.
Consult Pharm. 2013 Jun;28(6):361-9. doi: 10.4140/TCP.n.2013.361.
To evaluate the appropriateness/inappropriateness of medication prescribing using the Screening Tool of Older Person's Prescriptions/Screening Tool to Alert doctors to Right Treatment (STOPP/START) criteria in elderly homebased primary care (HBPC) veterans and to understand the potential impact of the HBPC team on the STOPP/START criteria.
Retrospective chart review between September 1, 2007, and September 30, 2009.
Edward Hines, Jr. VA Hospital, Hines, Illinois, a tertiary care referral center.
Two hundred patients 65 years of age and older who had an initial interdisciplinary evaluation conducted by the HBPC team. Exclusion criteria included admission to the hospital between the initial and follow-up medication review, admission to the HBPC program for palliative or hospice care, or death before completion of a follow-up evaluation.
Appropriateness/inappropriateness of medication prescribing was assessed by comparing the medication list at the initial pharmacist medication review and follow-up review. Initial and follow-up STOPP and START scores were calculated for each patient.
The primary outcome was to evaluate the appropriateness/inappropriateness of medication prescribing using the STOPP/START criteria. The secondary outcome was to understand the potential impact of the HBPC team on the STOPP/START criteria.
There was a statistically significant decrease in the STOPP score between the initial and follow-up medication review (P = 0.0014). There was not a statistically significant increase in the START score between the initial and follow-up medication review (P = 0.5720).
A statistically significant decrease in the STOPP score was found. Although the START score increased, the change was not found to be statistically significant.
使用老年人处方筛查工具/提醒医生正确治疗的筛查工具(STOPP/START)标准,评估老年居家初级保健(HBPC)退伍军人用药处方的适宜性/不适宜性,并了解HBPC团队对STOPP/START标准的潜在影响。
2007年9月1日至2009年9月30日的回顾性病历审查。
伊利诺伊州海因斯的小爱德华·海因斯退伍军人医院,一家三级医疗转诊中心。
200名65岁及以上的患者,他们接受了HBPC团队的首次多学科评估。排除标准包括在初始和随访药物审查之间住院、因姑息或临终关怀入院参加HBPC项目或在完成随访评估前死亡。
通过比较初始药剂师药物审查和随访审查时的药物清单,评估用药处方的适宜性/不适宜性。为每位患者计算初始和随访时的STOPP和START分数。
主要观察指标是使用STOPP/START标准评估用药处方的适宜性/不适宜性。次要观察指标是了解HBPC团队对STOPP/START标准的潜在影响。
初始和随访药物审查之间,STOPP分数有统计学意义的下降(P = 0.0014)。初始和随访药物审查之间,START分数没有统计学意义的增加(P = 0.5720)。
发现STOPP分数有统计学意义的下降。虽然START分数有所增加,但未发现变化具有统计学意义。